Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients
Clinical trial NCT05119686 · COMPLETED
Trial details
- NCT number
- NCT05119686
- Sponsor
- Arthrosi Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-16
- Primary completion
- 2022-11-17
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.